Status:
COMPLETED
Predicting Outcome in Cervix Carcinoma: a Prospective Study
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The main aim is to validate and improve the predictive model for survival and toxicity in patients with cervical cancer through multicentric prospective data collection. The data contain information o...
Eligibility Criteria
Inclusion
- histological or cytological proven cervical cancer
- informed consent according to national rules
Exclusion
- no histological or cytological proven cervical cancer
- no informed consent according to national rules
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
423 Patients enrolled
Trial Details
Trial ID
NCT01825005
Start Date
February 1 2013
End Date
August 1 2018
Last Update
May 10 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Hospital
Maastricht, Netherlands
2
Bloemfontein medicross
Bloemfontein, Free State, South Africa